
Results
11
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
11 companies
AddLife
Market Cap: SEK 19.6b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 160.80
7D
5.6%
1Y
-19.0%
Bonesupport Holding
Market Cap: SEK 15.0b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 227.40
7D
0.5%
1Y
-10.2%
Swedencare
Market Cap: SEK 4.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 27.70
7D
0.4%
1Y
-34.7%
Devyser Diagnostics
Market Cap: SEK 1.5b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 89.70
7D
-2.7%
1Y
-21.3%
Cinclus Pharma Holding
Market Cap: SEK 565.9m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 12.16
7D
-0.5%
1Y
-30.6%
Mendus
Market Cap: SEK 312.9m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 5.10
7D
0.6%
1Y
-20.6%
Promimic
Market Cap: SEK 198.4m
Engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden.
PRO
SEK 10.50
7D
-7.9%
1Y
-48.5%
Diamyd Medical
Market Cap: SEK 178.2m
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 1.15
7D
2.5%
1Y
-88.4%
IDL Diagnostics
Market Cap: SEK 104.8m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.46
7D
-7.0%
1Y
-15.1%
Alzinova
Market Cap: SEK 75.3m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.49
7D
9.0%
1Y
-72.7%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%